Gyeongnam Pharmaceutical Square "Initial Batch of Lemona Sold Out on B2E New Distribution Platform 'No Money Market'"

[Asia Economy Reporter Jang Hyowon] Gyeongnam Pharmaceutical Square announced on the 22nd that it has sold out the initial stock of Lemona sold on its newly launched B2E-type new distribution platform, 'No Money Market.'

Launched on the 15th, No Money Market is a new distribution platform in the 'Buy to Earn' format, where products are sold to consumers and rewards for consumers' purchases and activities are given in the form of NFTs. The NFTs received can be converted into 'Lemon Coin,' issued independently by Gyeongnam Pharmaceutical Square, allowing consumers to receive economic rewards even after purchasing products.

Having achieved a sell-out of the initial Lemona stock, Gyeongnam Pharmaceutical Square is preparing to supply additional stock to No Money Market and plans to sell its own products, masks, and products from other companies together.

Additionally, by utilizing Lemona to enhance brand value, the parent company Gyeongnam Pharmaceutical plans to expand the ecosystem offline based on its distribution network and over 12,000 clients, including large supermarkets, drugstores, and pharmacies secured as a priority.

A company representative said, "We are grateful to the many consumers who showed interest as we sold out the initial Lemona stock within five days of launching the B2E new distribution platform No Money Market," adding, "Building on the sell-out of the initial stock, we will firmly establish our position as a new distribution platform by selling other products alongside Lemona."

This content was produced with the assistance of AI translation services.